PANCLARITY

Serial Number 87388254
606

Registration Progress

Application Filed
Mar 28, 2017
Under Examination
Sep 26, 2017
Approved for Publication
Aug 1, 2017
Published for Opposition
Aug 1, 2017
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: PANCLARITY
Previous Owner: Sagent Pharmaceuticals, Inc.
Classes: 005

Trademark Image

PANCLARITY

Basic Information

Serial Number
87388254
Filing Date
March 28, 2017
Published for Opposition
August 1, 2017
Abandonment Date
April 30, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Apr 30, 2018
Classes
005

Rights Holder

Sagent Pharmaceuticals, Inc.

03
Address
1901 North Roselle Road
Schaumburg, IL 60195

Ownership History

Sagent Pharmaceuticals, Inc.

Original Applicant
03
Schaumburg, IL

Sagent Pharmaceuticals, Inc.

Owner at Publication
03
Schaumburg, IL

Legal Representation

Attorney
Eric R. Moran

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

11 events
Date Code Type Description Documents
Apr 30, 2018 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Apr 30, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Sep 26, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 1, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 1, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 12, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 21, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 20, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 1, 2017 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
Mar 31, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 31, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of chronic pancreatitis; oral serine protease inhibitor for the treatment of chronic pancreatitis
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
PAN CLARITY

Classification

International Classes
005